Loading
Cipher Pharmaceuticals Inc. Stock: price and insider trades · Canada
CA·Mcap CA$346.9M
Cipher Pharmaceuticals Inc.: what insiders have been doing
Every trade that managers of Cipher Pharmaceuticals Inc. disclose to SEDI is tracked on this page. From 18 October 2025 to 18 October 2026, the disclosure feed for Cipher Pharmaceuticals Inc. logged 28 filings by 7 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
There has been no open-market purchase by an insider of Cipher Pharmaceuticals Inc. for at least a year. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade.
Across the 2,130 companies tracked on its exchange, the median is 12 filings; at 28 filings, this issuer sits above that mark.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
29
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Who traded when
BuySaleCraig Mull1 buy1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,348 of 24,148 companies
78.1
score / 100
Value65
Quality91
FCF yld8.6%
Earn yld7.9%
EV/EBITDA14.5x
ROE24%
Gross mgn80%
Net mgn54%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$13.65
Analyst consensus
4 analysts1.75/5
CA$17.00Target CA$19.45(+42%)CA$21.30
Income statement
RevenueCA$50.5M
Gross profitCA$40.4M80% margin
EBITDACA$24.1M48% margin
Net incomeCA$27.3M58.4% margin
Valuation
PER (trailing)8.9x
P/Book1.8x
Beta0.41
Balance sheet & cash
Market capCA$346.9M
Total debtCA$5.5M
Free Cash FlowCA$29.5M
Debt / Equity0%
Profitability & ownership
ROE23.5%
ROA8.0%
% insiders42.5%
% institutions1.3%
Last declaration on 2 October 2026
Declarations29 total
2,500 sharesRestricted Share UnitsTSXSEDI:4785487
Restricted Share UnitsTSXSEDI:4785481
5,000 shares@ CA$13.650.020% mcap11.1% of flowOptionsTSXSEDI:4785469
40,000 shares@ CA$13.650.16% mcap88.9% of flowOptionsTSXSEDI:4785465
OptionsTSXSEDI:4785455
133,245 shares@ CA$14.480.55% mcap50.0% of flowCommon SharesTSXSEDI:4784513
20,000 shares@ CA$1.180.0066% mcap1.4% of flowCommon SharesTSXSEDI:4780213
20,000 shares@ CA$14.160.080% mcap16.3% of flowOptionsTSXSEDI:4780211
1,149 shares@ CA$16.310.0047% mcap10.3% of flowCommon SharesTSXSEDI:4740114
2,500 shares@ CA$16.190.010% mcap22.3% of flowRestricted Share UnitsTSXSEDI:4740109
1,149 shares@ CA$16.310.0047% mcap10.3% of flowCommon SharesTSXSEDI:4740089
2,500 shares@ CA$16.190.010% mcap22.3% of flowRestricted Share UnitsTSXSEDI:4740054
2,500 shares@ CA$16.190.010% mcap2.3% of flowRestricted Share UnitsTSXSEDI:4740034
2,500 shares@ CA$16.340.010% mcap22.5% of flowRestricted Share UnitsTSXSEDI:4740020
2,500 shares@ CA$16.340.010% mcap22.5% of flowRestricted Share UnitsTSXSEDI:4740017
2,500 shares@ CA$16.330.010% mcap2.3% of flowRestricted Share UnitsTSXSEDI:4740016
5,000 shares@ CA$16.330.021% mcap44.9% of flowOptionsTSXSEDI:4740015
5,000 shares@ CA$16.330.021% mcap44.9% of flowOptionsTSXSEDI:4740014
1,837 shares@ CA$16.330.0075% mcap100.0% of flowOptionsTSXSEDI:4740012
15,309 shares@ CA$16.330.063% mcap100.0% of flowOptionsTSXSEDI:4740011
5,000 shares@ CA$16.330.021% mcap4.7% of flowOptionsTSXSEDI:4740009
78,007 shares@ CA$16.340.32% mcap73.0% of flowOptionsTSXSEDI:4740007
75,000 shares@ CA$14.53100.0% of flowOptionsTSXSEDI:4731738
100,000 shares@ CA$14.5348.2% of flowOptionsTSXSEDI:4731683
5,000 shares@ CA$0.900.2% of flowOptionsTSXSEDI:4731677
25 of 29 declarations
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. is a Canadian company focused on the development and commercialization of pharmaceutical products. It specializes in treatments for dermatological diseases and other medical conditions.
